Months of coverage acquired | Fluralaner (%) | Afoxalaner (%) | Spinosad (%) |
---|---|---|---|
1.0–1.9 | Not applicable | 30.3 | 37.2 |
2.0–2.9 | 42.1a | 21.6 | 30.1 |
3.0–3.9 | 1.6 | 1.1 | 1.2 |
4.0–4.9 | 1.5 | 4.5 | 6.3 |
5.0–5.9 | 22.1 | 15.6 | 13.0 |
6.0–6.9 | 2.1 | 2.4 | 1.7 |
7.0–7.9 | 2.2 | 3.9 | 2.2 |
8.0–8.9 | 10.3 | 2.7 | 1.5 |
9.0–9.9 | 2.4 | 3.7 | 1.3 |
10.0–10.9 | 3.4 | 1.9 | 0.7 |
11.0–11.9 | 8.4 | 6.6 | 3.0 |
12.0 | 4.0 | 5.6 | 1.7 |